文献速递心脑血管急症重症综合管理与镇静镇痛

重型TBI患者甘露醇治疗后压力平衡比改善:潜在床旁治疗反应标志物的初步研究

Improved Pressure Equalization Ratio Following Mannitol Administration in Patients With Severe TBI: A Preliminary Study of a Potential Bedside Marker for Response to Therapy.
PubMed 文献 · Neurocrit Care · 2021-09-08
一句话结论重型TBI伴颅内压升高患者,甘露醇后压力平衡比(PE ratio)从0.29升至0.62,提示脑脊液引流降ICP能力改善。

本研究为单中心初步研究,纳入20例重型TBI、CT示脑水肿且置入脑室外引流(EVD)的神经重症患者,在临床指征下因ICP升高接受甘露醇治疗,于给药前后测量PE ratio(引流前ICP减引流后ICP,除以引流前ICP减EVD高度)。甘露醇前平均ICP为29±7 mm Hg,给药后PE ratio由0.29±0.20升至0.62±0.24(p<0.0001);甘露醇联合脑脊液引流较单用前使ICP多降低(11±2 vs 6±2 mm Hg,p<0.01),77%病例ICP降至20 mm Hg以下。提示PE ratio可能作为脑水肿治疗反应的床旁标志物,但需进一步验证。

要点

  • 适用对象为重型TBI、CT示脑水肿、已置入EVD且因ICP升高按临床指征使用甘露醇的患者(n=20)。
  • PE ratio定义为(引流前ICP−引流后ICP)/(引流前ICP−EVD高度),甘露醇后由0.29±0.20升至0.62±0.24(p<0.0001)。
  • 甘露醇前平均ICP为29±7 mm Hg;甘露醇后联合脑脊液引流ICP降幅11±2 mm Hg,优于用药前的6±2 mm Hg(p<0.01)。
  • 甘露醇联合引流后77%病例ICP降至20 mm Hg以下。
  • PE ratio为初步探索性标志物,原文明确需进一步研究验证其作为脑水肿程度替代标志物的价值。

适用人群与场景

  • 连续纳入神经重症监护病房的重型TBI患者,CT示脑水肿并已置入EVD。
  • 因临床指征出现ICP升高而接受甘露醇治疗者;原文未列出其他纳入或排除标准。

诊断标准与关键阈值

  • PE ratio=(脑脊液引流前ICP−引流后ICP)/(引流前ICP−EVD高度),按原文先前描述的方法测量。
  • ICP升高及甘露醇使用基于临床指征判断,原文未给出具体启动阈值。
  • 原文以ICP低于20 mm Hg作为降颅压达标界值。

处置流程与药物剂量

  • 第一步:对重型TBI伴脑水肿且置入EVD的患者,在临床指征下因ICP升高给予甘露醇(原文未提及剂量、途径、频次)。
  • 第二步:于甘露醇给药前后分别测量PE ratio。
  • 第三步:甘露醇后行脑脊液引流,评估ICP降幅及是否降至20 mm Hg以下。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 单中心初步研究,纳入20例重型TBI伴ICP升高的患者,无对照组。
  • 甘露醇前平均ICP为29±7 mm Hg。
  • 甘露醇后PE ratio由0.29±0.20升至0.62±0.24(p<0.0001)。
  • 甘露醇联合脑脊液引流ICP降幅11±2 mm Hg,用药前为6±2 mm Hg(p<0.01)。
  • 77%病例甘露醇后ICP降至20 mm Hg以下。

证据类型、等级与局限

  • 研究类型:单中心初步研究(自身前后对照),样本量20例。
  • 局限:样本小、单中心、无对照组、初步探索性,PE ratio作为脑水肿替代标志物需进一步研究验证。

对床旁实践的改变

  • 提示可在已置入EVD的重型TBI伴ICP升高患者中,于甘露醇前后测量PE ratio以评估脑脊液引流降ICP的反应。
  • 甘露醇后行脑脊液引流可能获得更大ICP降幅,但原文为初步研究,不能据此确立PE ratio为常规决策阈值。
  • 不适用于未置入EVD或非重型TBI脑水肿患者;原文未提及甘露醇剂量方案,不能据此形成给药推荐。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Performing a cerebrospinal fluid (CSF) drainage challenge can be used to measure the pressure equalization (PE) ratio, which describes the extent to which CSF drainage can equalize pressure to the height of the external ventricular drain and may serve as a correlate of cerebral edema. We sought to assess whether treatment with mannitol improves PE ratio in patients with severe traumatic brain injury (TBI) with elevated intracranial pressure (ICP).

METHODS: We studied consecutive patients with TBI and brain edema on computed tomography scan and an external ventricular drain (EVD), admitted to the neurointensive care unit. PE ratio, defined as ICP prior to CSF drainage minus ICP after CSF drainage divided by ICP prior to CSF drainage minus EVD height, was measured as previously described. Patients were treated with mannitol for raised ICP based on clinical indication and PE ratio measured before and after mannitol administration.

RESULTS: We studied 20 patients with severe TBI with raised ICP. Mean ICP prior to mannitol treatment was 29 ± 7 mm Hg. PE ratio rose substantially after mannitol treatment (0.62 ± 0.24 vs. 0.29 ± 0.20, p < 0.0001), indicating an improved ability to drain CSF and equalize ICP with the preset height of the EVD. The combination of mannitol and CSF drainage led to an improved reduction in ICP compared with that seen before mannitol therapy (11 ± 2 mm Hg vs. 6 ± 2 mm Hg, p < 0.01), and led to a decrease in ICP below the 20 mm Hg threshold in 77% of cases.

CONCLUSIONS: Treatment with mannitol leads to a substantial improvement in PE ratio that reflects the ability to achieve a greater decrease in ICP when CSF drainage is performed after mannitol administration. This preliminary study raises the possibility that PE ratio may be useful to follow response to therapy in patients with cerebral edema and raised ICP. Further studies to determine whether PE ratio may serve as an easily obtained and clinically useful surrogate marker for the extent of brain edema are warranted.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Doron O, Hemphill JC, Manley G, et al. Improved Pressure Equalization Ratio Following Mannitol Administration in Patients With Severe TBI: A Preliminary Study of a Potential Bedside Marker for Response to Therapy. Neurocrit Care. 2021. PMID: 34498204. doi:10.1007/s12028-021-01332-y

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。